Kodo Tomida

Learn More
The combination of serum 25-hydroxyvitamin D (25D) and fibroblast growth factor 23 (FGF23) levels predict hard renal outcomes in patients with chronic kidney disease (CKD), independent of classical markers of mineral and bone disorders, including serum phosphorus, parathyroid hormone, 1,25-dihydroxyvitamin D levels, and active vitamin D therapy. In a(More)
S-1 and cisplatin are used as one of the first-line chemotherapies for gastric cancer in Japan. The plasma concentration of 5-fluorouracil (5-FU) is increased in patients with renal dysfunction because gimeracil in S-1 inhibits the degradation of 5-FU and about 50% of gimeracil is excreted in the urine. We describe a 35-year-old man with acute kidney injury(More)
Image in nephrology A 21-year-old woman was diagnosed with Hodgkin's lym-phoma (stage IV-B) in 2001 and underwent chemotherapy and then three stem cell transplantations [auto-peripheral blood stem cell transplantation (PBSCT) in 2002, allo-bone marrow transplantation from her mother in 2002 and allo-PBSCT from her sister in 2003]. From 2004, her serum(More)
  • 1